IS SERUM PROSTATE‑SPECIFIC ANTIGEN A DIAGNOSTIC MARKER FOR BENIGN AND MALIGNANT BREAST TUMORS IN WOMEN?

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

EMAMI RAZAVI SEYED HASAN; GHAJARZADEH MAHSA; ABDOLLAHI ALIREZA; SHOAR SAEED; OMRANIPOUR RAMESH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: International Journal of Preventive Medicine Year:2015 | Volume:6 | Issue:2 Page(s): 0-0

Download Full-Text

View:

286

Download:

Cites:

Information Journal Paper

Title

IS SERUM PROSTATE‑SPECIFIC ANTIGEN A DIAGNOSTIC MARKER FOR BENIGN AND MALIGNANT BREAST TUMORS IN WOMEN?

Author(s)

Keywords

BREAST

DIAGNOSIS

PROSTRATE‑SPECIFIC ANTIGEN

Abstract

Background: BREAST cancer is the most common cancer in women. Prostate‑specific antigen (PSA) is a marker of prostate gland malignancy, which has been considered in cases with BREAST cancer in recent years. The goal of this study was to determine total and free PSA levels in cases with malignant and benign BREAST lesions.Methods: In this case–control study, ninety women with histological proved malignant BREAST masses and 90 with benign BREAST masses were enrolled. Total and free PSA levels along with Histological grade and conditions of vascular and perinural invasion, status of hormonal tumor receptors, immune‑histo‑chemistry markers recorded for all cases. Total and free PSA levels were assessed after treatment in cases with malignant masses.Results: Total and free PSA levels were significantly higher in cases with malignant masses. The best cut‑off point for total PSA to differentiate benign and malignant masses was 0.31 with sensitivity and specificity of 100%, 100% (area under the curve [AUC] =1, P<0.001) and the best cut‑off point for free PSA to differentiate benign and malignant masses was 0.19 with sensitivity and specificity of 100% and 100% (AUC = 1, P<0.001). After treatment, mean free PSA level was significantly lower than free PSA before treatment (0.23±0.1 vs. 0.3±0.08, P<0.001).Conclusions: Serum PSA level could be applied for differentiating benign and malignant BREAST masses.

Cites

No record.

References

No record.

Cite

APA: Copy

EMAMI RAZAVI, SEYED HASAN, GHAJARZADEH, MAHSA, ABDOLLAHI, ALIREZA, SHOAR, SAEED, & OMRANIPOUR, RAMESH. (2015). IS SERUM PROSTATE?SPECIFIC ANTIGEN A DIAGNOSTIC MARKER FOR BENIGN AND MALIGNANT BREAST TUMORS IN WOMEN?. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 6(2), 0-0. SID. https://sid.ir/paper/316274/en

Vancouver: Copy

EMAMI RAZAVI SEYED HASAN, GHAJARZADEH MAHSA, ABDOLLAHI ALIREZA, SHOAR SAEED, OMRANIPOUR RAMESH. IS SERUM PROSTATE?SPECIFIC ANTIGEN A DIAGNOSTIC MARKER FOR BENIGN AND MALIGNANT BREAST TUMORS IN WOMEN?. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE[Internet]. 2015;6(2):0-0. Available from: https://sid.ir/paper/316274/en

IEEE: Copy

SEYED HASAN EMAMI RAZAVI, MAHSA GHAJARZADEH, ALIREZA ABDOLLAHI, SAEED SHOAR, and RAMESH OMRANIPOUR, “IS SERUM PROSTATE?SPECIFIC ANTIGEN A DIAGNOSTIC MARKER FOR BENIGN AND MALIGNANT BREAST TUMORS IN WOMEN?,” INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, vol. 6, no. 2, pp. 0–0, 2015, [Online]. Available: https://sid.ir/paper/316274/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops